Arteriogenesis	0	14	O
:	14	15	O
the	16	19	O
development	20	31	O
and	32	35	O
growth	36	42	O
of	43	45	O
collateral	46	56	B-Multi-tissue_structure
arteries	57	65	I-Multi-tissue_structure
.	65	66	O

In	68	70	O
patients	71	79	B-Organism
with	80	84	O
atherosclerotic	85	100	O
vascular	101	109	O
diseases	110	118	O
,	118	119	O
collateral	120	130	B-Multi-tissue_structure
vessels	131	138	I-Multi-tissue_structure
bypassing	139	148	O
major	149	154	O
arterial	155	163	B-Pathological_formation
obstructions	164	176	I-Pathological_formation
have	177	181	O
frequently	182	192	O
been	193	197	O
observed	198	206	O
.	206	207	O

This	208	212	O
may	213	216	O
explain	217	224	O
why	225	228	O
some	229	233	O
patients	234	242	B-Organism
remain	243	249	O
without	250	257	O
symptoms	258	266	O
or	267	269	O
signs	270	275	O
of	276	278	O
ischemia	279	287	O
.	287	288	O

The	289	292	O
term	293	297	O
"	298	299	O
arteriogenesis	299	313	O
"	313	314	O
was	315	318	O
introduced	319	329	O
to	330	332	O
differentiate	333	346	O
the	347	350	O
formation	351	360	O
of	361	363	O
collateral	364	374	B-Multi-tissue_structure
arteries	375	383	I-Multi-tissue_structure
from	384	388	O
angiogenesis	389	401	O
,	401	402	O
which	403	408	O
mainly	409	415	O
occurs	416	422	O
in	423	425	O
the	426	429	O
ischemic	430	438	O
,	438	439	O
collateral	440	450	O
flow	451	455	O
-	455	456	O
dependent	456	465	O
tissue	466	472	B-Tissue
.	472	473	O

Many	474	478	O
observations	479	491	O
in	492	494	O
various	495	502	O
animal	503	509	O
models	510	516	O
and	517	520	O
humans	521	527	B-Organism
support	528	535	O
that	536	540	O
the	541	544	O
remodeling	545	555	O
of	556	558	O
preexisting	559	570	O
collateral	571	581	B-Multi-tissue_structure
vessels	582	589	I-Multi-tissue_structure
is	590	592	O
the	593	596	O
mechanism	597	606	O
of	607	609	O
collateral	610	620	B-Multi-tissue_structure
artery	621	627	I-Multi-tissue_structure
formation	628	637	O
.	637	638	O

This	639	643	O
remodeling	644	654	O
process	655	662	O
seems	663	668	O
to	669	671	O
be	672	674	O
mainly	675	681	O
flow	682	686	O
-	686	687	O
mediated	687	695	O
.	695	696	O

It	697	699	O
involves	700	708	O
endothelial	709	720	B-Cell
cell	721	725	I-Cell
activation	726	736	O
,	736	737	O
basal	738	743	B-Cellular_component
membrane	744	752	I-Cellular_component
degradation	753	764	O
,	764	765	O
leukocyte	766	775	B-Cell
invasion	776	784	O
,	784	785	O
proliferation	786	799	O
of	800	802	O
vascular	803	811	B-Cell
cells	812	817	I-Cell
,	817	818	O
neointima	819	828	B-Tissue
formation	829	838	O
(	839	840	O
in	840	842	O
most	843	847	O
species	848	855	O
studied	856	863	O
)	863	864	O
,	864	865	O
and	866	869	O
changes	870	877	O
of	878	880	O
the	881	884	O
extracellular	885	898	B-Cellular_component
matrix	899	905	I-Cellular_component
.	905	906	O

The	907	910	O
contribution	911	923	O
of	924	926	O
ischemia	927	935	O
to	936	938	O
arteriogenesis	939	953	O
is	954	956	O
still	957	962	O
unclear	963	970	O
,	970	971	O
but	972	975	O
arteriogenesis	976	990	O
clearly	991	998	O
can	999	1002	O
occur	1003	1008	O
in	1009	1011	O
the	1012	1015	O
absence	1016	1023	O
of	1024	1026	O
any	1027	1030	O
significant	1031	1042	O
ischemia	1043	1051	O
.	1051	1052	O

It	1053	1055	O
is	1056	1058	O
questionable	1059	1071	O
,	1071	1072	O
whether	1073	1080	O
collateral	1081	1091	B-Multi-tissue_structure
arteries	1092	1100	I-Multi-tissue_structure
also	1101	1105	O
form	1106	1110	O
de	1111	1113	O
novo	1114	1118	O
in	1119	1121	O
ischemic	1122	1130	O
vascular	1131	1139	O
diseases	1140	1148	O
.	1148	1149	O

A	1150	1151	O
better	1152	1158	O
understanding	1159	1172	O
of	1173	1175	O
the	1176	1179	O
mechanisms	1180	1190	O
of	1191	1193	O
arteriogenesis	1194	1208	O
will	1209	1213	O
be	1214	1216	O
important	1217	1226	O
for	1227	1230	O
the	1231	1234	O
design	1235	1241	O
of	1242	1244	O
more	1245	1249	O
effective	1250	1259	O
strategies	1260	1270	O
for	1271	1274	O
the	1275	1278	O
treatment	1279	1288	O
of	1289	1291	O
patients	1292	1300	B-Organism
with	1301	1305	O
ischemic	1306	1314	O
vascular	1315	1323	O
diseases	1324	1332	O
.	1332	1333	O

